Yes good, but I fear the cashflow result has put a bit of a dampener on it. Expectations were bigger. I'm not concerned but market seems to be.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025